Abstract
Under the multivariate normal setup, the bioequivalence problem is studied, using the confidence approach. First a confidence set which has smallest expected effective length at the origin is proposed. For the known variance case, its induced test can be shown to have constant level α. Also, it is unbiased and uniformly most powerful among equivariant tests. For the unknown variance case, an approximated confidence set is proposed. The induced test enjoys similar good properties. Simulation shows that our test substantially outperforms some existing tests, in general.
Similar content being viewed by others
References
Anderson, S. andHauck, W. W. (1983). A new procedure for testing equivalence in comparative bioavailability and other clinical trials.Communications in Statistics Theory and Methods, 12:2663–2692.
Berger, R. L. andHsu, J. C. (1996). Bioequivalence trials, intersection-union tests and equivalence confidence sets.Statistical Science, 11(4):283–319.
Bofinger, E., Hayter, A. J., andLiu, W. (1993). The construction of upper confidence bounds on the range of several location parameters.Journal of American Statistical Association, 88:906–911.
Brown, L. D., Casella, G., andHwang, J. T. G. (1995). Optimal confidence sets, bioequivalence, and the limacon of Pascal.Journal of the American Statistical Association, 90(431):880–889.
Brown, L. D., Hwang, J. T. G. andMunk, A. (1997). An unbiased test for the bioequivalence problem.Annals of Statistics, 25(6):2345–2367.
Chow, S. C. andLiu, J. P. (1992).Design and Analysis of Bioavailability and Bioequivalence Studies. Marcel Dekker, Inc., New York.
Ghosh, J. K. (1961). On the relation among shortest confidence intervals of different types.Calcutta Statistical Association Bulletin, pp. 147–152.
Giani, G. andFinner, H. (1991). Some general results on least favorable parameter configurations with special reference to equivalence testing and the range statistic.Journal of Statistical Planning and Inference, 28:33–47.
Hsu, J. C., Hwang, J. T. G., Liu, H. K. andRuberg, S. J. (1994). Equivalence confidence intervals in bioequivalence trials.Biometrika, 81:103–114.
Hsu, J. C. andRuberg, S. J. (1992). Equivalence confidence intervals in bioequivalence trials. Technical report, Ohio State University, Columbus, Ohio.
Hwang, J. T. G., andLiu, H. K. (1992). Symmetric confidence intervals associated with tests for bioequivalence. Technical report, Cornell University, Ithaca, New York.
Metzler, C. M. (1972). Bioavailability—a problem in equivalence.Biometrics, 30:309–317.
Patel, H. L. andGupta, G. (1984). A problem of equivalence in clinical trials.Biomedical Journal, 26:471–474.
Pratt, J. W. (1961). Length of confidence intervals.Journal of the American Statistical Association, 56:541–567.
Rocke, D. M. (1984). On testing for bioequivalence.Biometrics, 40:225–230.
Schuirmann, D. J. (1987). A comparison of the two one-sided test procedure and the power approach for assessing the equivalence of average bioavailability.Journal of Pharmokinetics and Biopharmaceutics, 15:657–680.
Tseng, Y. L. andBrown, L. D. (1997). Good exact confidence sets for a multivariate normal mean.Annals of Statistics, 25(5):2228–2258.
Wang, W., Hwang, J. T. G. andDas Gupta, A. (1999). Statistical tests for multivariate bioequivalence.Biometrika, 86(2):395–402.
Westlake, W. J. (1972). Use of confidence intervals in analysis of comparative bioavailability trials.Journal of Pharmaceutical Science, 61:1340–1341.
Westlake, W. J. (1976). Symmetrical confidence intervals for bioequivalence trials.Biometrics, 32:741–744.
Westlake, W. J. (1979). Statistical aspects of comparative bioavailability trials.Biometrics, 32:273–280.
Author information
Authors and Affiliations
Corresponding author
Additional information
This research was supported in part by NSC, Taiwan, grant No. 84-2121-M-001-031
Rights and permissions
About this article
Cite this article
Tseng, YL. Optimal confidence sets for testing average bioequivalence. Test 11, 127–141 (2002). https://doi.org/10.1007/BF02595733
Issue Date:
DOI: https://doi.org/10.1007/BF02595733
Key Words
- Average bioequivalence
- Confidence set
- Effective length
- Multivariate bioequivalence testing
- Optimal bioequivalence test